2021-01-11,Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference
2020-12-04,DFFN: Planning for Additional Studies of TSC
2020-11-29,Is Diffusion Pharmaceuticals Inc. (DFFN) A Good Stock To Buy?
2020-11-18,Insider Buys Diffusion Pharmaceuticals Shares
2020-11-12,Diffusion Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Updates
2020-10-19,Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer
2020-09-24,Diffusion Pharmaceuticals Strengthens Management Team with Appointment of William Elder as General Counsel and Corporate Secretary
2020-09-17,DFFN: First Patients Dosed in COVID-19 Trial
2020-09-15,We Think Diffusion Pharmaceuticals (NASDAQ:DFFN) Can Afford To Drive Business Growth
2020-09-11,Diffusion Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual  Virtual Global Investment Conference
2020-09-10,Diffusion Pharmaceuticals Doses First Two Patients with TSC in COVID-19 Clinical Trial
2020-09-08,Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer
2020-09-01,Diffusion Pharmaceuticals Appoints Jane H. Hollingsworth to its Board of Directors
2020-08-24,DFFN: ARDS Trial Set to Get Underway
2020-08-10,Diffusion Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
2020-07-27,Diffusion Pharmaceuticals Receives FDA Guidance for International Phase 1b/2b COVID-19 Clinical Program with TSC
2020-07-07,Diffusion Pharmaceuticals Files IND for International Phase 1b/2b COVID-19 Clinical Program With TSC
2020-07-06,3 Coronavirus Penny Stocks With Triple-Digit Upside Potential
2020-06-11,Diffusion Pharmaceuticals Files Clinical Trial Application for European Phase 1a/1b Study of TSC in COVID-19 Patients
2020-06-01,Diffusion Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement
2020-05-26,Diffusion Pharmaceuticals Receives Accelerated FDA Response to Proposed TSC COVID-19 Clinical Trial Program
2020-05-20,Diffusion Pharmaceuticals Inc. Announces Closing of $12.0 Million Registered Direct Offering Priced At-the-Market
2020-05-20,Diffusion Pharmaceuticals Expands Clinical Trial Program of TSC for the Treatment of COVID-19 Patients to Include the Romanian National Institute of Infectious Diseases
2020-05-19,Johns Hopkins doctor on Trump's preventative hydroxychloroquine use: 'hopefully other people will not follow this example'
2020-05-19,DFFN: TSC to be Tested as Treatment for ARDS Caused by COVID-19
2020-05-18,Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
2020-05-11,Diffusion Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
2020-05-05,Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS
2020-04-27,Diffusion Pharmaceuticals Announces Pre-IND Submission to the FDA of Design for TSC Trials to Treat Acute Respiratory Distress Syndrome in COVID-19
2020-04-03,DFFN: Evaluating TSC as Potential Treatment for ARDS
2020-04-01,Diffusion Pharmaceuticals Evaluating TSC Against Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients
2020-03-24,Diffusion Pharmaceuticals Anticipates Enrollment in its Ambulance-based Stroke Trial Will be Slowed Due to the Impact of the Coronavirus
2020-03-19,Is Diffusion Pharmaceuticals (NASDAQ:DFFN) In A Good Position To Deliver On Growth Plans?
2020-03-18,CORRECTION -- Diffusion Pharmaceuticals Reports 2019 Financial Results and Provides Business Update
2020-03-17,Diffusion Pharmaceuticals Reports 2019 Financial Results and Provides Business Update
2020-03-12,Diffusion Pharmaceuticals Announces Retirement of Chief Science Officer John L. Gainer
2020-02-07,Diffusion Pharmaceuticals Receives European Patent Related Compositions of TSC
2020-01-10,"Diffusion Pharmaceuticals Appoints Life Sciences Veteran Dr. Robert Cobuzzi, Jr. to its Board of Directors"
2019-12-30,DFFN: Highly Encouraging Data from Run-in Portion of Phase 3 GBM Trial
2019-12-22,Hedge Funds Have Never Been More Bullish On Diffusion Pharmaceuticals Inc. (DFFN)
2019-12-13,Diffusion Pharmaceuticals Inc. Announces Closing of $3.5 Million Offering Priced At-the-Market
2019-12-12,CORRECTING and REPLACING  Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
2019-12-12,Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
2019-12-11,"The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint"
2019-12-10,Diffusion Pharmaceuticals Presents Data Suggesting Optimized TSC Dosing Regimen Increases Survival in Newly Diagnosed Inoperable Glioblastoma Patients
2019-11-20,"The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data"
2019-11-19,Diffusion Pharmaceuticals Presents Early Findings Showing Increased Survival in Lead-in Portion of Phase 3 Glioblastoma Study with TSC plus Standard of Care
2019-11-15,Diffusion Pharmaceuticals Announces Closing of $4.0 Million Public Offering
2019-11-13,Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
2019-11-11,Diffusion Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update
2019-10-17,First Patient Enrolled in Diffusion Pharmaceuticals Phase 2 On-Ambulance Clinical Trial with TSC for the Treatment of Stroke
2019-09-19,Will Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Need To Raise More Money?
2019-09-03,Diffusion Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference
2019-08-15,DFFN: Positive Safety Data for Dose Escalation Portion of Phase 3 GBM Trial
2019-08-08,Diffusion Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update
2019-07-23,Diffusion Pharmaceuticals Reports Favorable Safety Data for Dose-Escalation Run-in of Phase 3 INTACT Study in Glioblastoma Multiforme Patients
2019-07-11,The Diffusion Pharmaceuticals (NASDAQ:DFFN) Share Price Is Down 98% So Some Shareholders Are Very Salty
2019-05-28,Diffusion Pharmaceuticals Inc. Announces Closing of $6.45 Million Offering Priced At-the-Market
2019-05-24,Diffusion Pharmaceuticals Inc. Announces $6.45 Million Registered Direct Offering & Private Placement
2019-05-23,Diffusion Pharmaceuticals Receives Notice of Intention to Grant a Patent Related to Use of TSC in Combination with tPA in Ischemic Stroke from European Patent Office
2019-05-13,DFFN: Phase 2 Study of TSC in Stroke to Start in Summer 2019
2019-05-09,Diffusion Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update
2019-04-17,DFFN: Data from Initial 8 Patients in Phase 3 GBM Trial Expected in mid-2019
2019-03-20,Diffusion Pharmaceuticals Reports 2018 Financial Results and Provides Business Update
2019-03-08,4 Stocks Join Ben Graham Net-Net Screener Friday
2019-02-11,Poster Presented at International Stroke Conference Describing Diffusions On-Ambulance Phase 2 Trial with TSC for Treating Acute Stroke
2019-01-22,How Does Investing In Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Impact The Volatility Of Your Portfolio?
2019-01-04,Diffusion Pharmaceuticals Chief Executive Officer David Kalergis to Present at 37th Annual J.P. Morgan Healthcare Conference
2019-01-03,Diffusion Pharmaceuticals Executes Successful NASDAQ Compliance Plan: Company Will Remain Listed on NASDAQ Stock Market
2018-12-18,Today's Research Reports on Trending Tickers: Evofem Biosciences and Diffusion Pharmaceuticals
2018-12-17,4 Stocks Providing Investor Opportunity Right Now
2018-12-17,U.S. Patent Office Awards Diffusion Exclusive Rights for Use of TSC in Conjunction with Only FDA-Approved Stroke Therapeutic
2018-12-13,Diffusion Pharmaceuticals Announces 1-for-15 Reverse Stock Split As Part Of NASDAQ Compliance Plan
2018-12-10,DFFN: Phase 2 Clinical Trial of TSC in Acute Stroke to Commence in 2019
2018-11-15,Diffusion Pharmaceuticals Chief Scientific Officer Dr. John L. Gainer to Present at 2018 Annual Meeting of the Society for NeuroOncology
2018-11-14,Diffusion Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update
2018-10-15,Diffusion Pharmaceuticals Chief Financial Officer William Bill Hornung to Present at 2018 BIO Investor Forum
2018-09-25,Diffusion Names William (Bill) Hornung Chief Financial Officer
2018-09-12,FDA Approves Start of Innovative On-Ambulance Phase 2 Clinical Trial for Treatment of Acute Stroke by Diffusion Pharmaceuticals
2018-08-29,Diffusion Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
2018-08-16,DFFN: Enrollment Continues in Phase 3 Trial of TSC in GBM
2018-08-13,Diffusion Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update
2018-06-12,Diffusion Pharmaceuticals Announces Validation of European Patent for Oral Formulations of TSC
2018-05-29,CORRECTION: Diffusion Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update
2018-05-15,DFFN: Preparing for Phase 2 Clinical Trial of TSC in Acute Stroke
2018-05-10,Diffusion Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update
2018-04-19,DFFN: Enrollment in Phase 3 GBM Trial Continuing
2018-04-03,Diffusion Pharmaceuticals to Present at The MicroCap Conference
2018-04-03,Diffusion Pharmaceuticals Reports 2017 Financial Results and Provides Business Update
2018-02-22,DFFN: Phase 3 GBM Trial Underway; Planning for Phase 2 Trial in Stroke
2018-02-06,Diffusion Pharmaceuticals to Present at the 2018 BIO CEO & Investor Conference
2018-02-01,Diffusion Pharmaceuticals Announces Allowances of Two U.S. Patent Applications
2018-01-29,Diffusion Pharmaceuticals Announces First Patient Dosed in Phase 3 Trial with TSC in Inoperable Glioblastoma Multiforme
2018-01-24,Abstract Outlining Pre-Hospital Stroke Study with Diffusion Pharmaceuticals TSC To Be Presented at the International Stroke Conference
2018-01-18,Diffusion Pharmaceuticals Inc (DFFN): Shoring up the Balance Sheet by Selling Stock Comes with a Price
2018-01-18,Diffusion Pharmaceuticals Announces $12 Million Underwritten Public Offering
2018-01-10,Todays Research Reports on Stocks to Watch: Diffusion Pharmaceuticals and Pain Therapeutics
2018-01-03,Diffusion Pharmaceuticals to Present at the 10th Annual Biotech Showcase Conference
2018-01-02,Breaking Down Diffusion Pharmaceuticals Incs (NASDAQ:DFFN) Ownership Structure
2017-12-27,Diffusion Pharmaceuticals Begins Phase 3 Clinical Trial with TSC in Glioblastoma Multiforme
